Lisa M Meckley

Summary

Affiliation: Tufts Medical Center
Country: USA

Publications

  1. doi request reprint Personalized medicine: factors influencing reimbursement
    Lisa M Meckley
    Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, 800 Washington St, 63, Boston, MA 02111, USA
    Health Policy 94:91-100. 2010
  2. doi request reprint The adoption of cost-effectiveness acceptability curves in cost-utility analyses
    Lisa M Meckley
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Med Decis Making 30:314-9. 2010
  3. doi request reprint Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement
    Peter J Neumann
    Center for Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Health Aff (Millwood) 30:2329-37. 2011

Detail Information

Publications3

  1. doi request reprint Personalized medicine: factors influencing reimbursement
    Lisa M Meckley
    Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, 800 Washington St, 63, Boston, MA 02111, USA
    Health Policy 94:91-100. 2010
    ..Personalized medicine (PM) has attracted tremendous interest, but yielded few marketed products. We examined factors influencing the reimbursement of existing PM technologies...
  2. doi request reprint The adoption of cost-effectiveness acceptability curves in cost-utility analyses
    Lisa M Meckley
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Med Decis Making 30:314-9. 2010
    ..g., life-years or quality-adjusted life-years gained)...
  3. doi request reprint Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement
    Peter J Neumann
    Center for Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Health Aff (Millwood) 30:2329-37. 2011
    ..For the foreseeable future, they are likely to remain the exception as drug companies pursue payment models unconnected to data collection or performance assessment...